JP2023090869A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023090869A5 JP2023090869A5 JP2023076299A JP2023076299A JP2023090869A5 JP 2023090869 A5 JP2023090869 A5 JP 2023090869A5 JP 2023076299 A JP2023076299 A JP 2023076299A JP 2023076299 A JP2023076299 A JP 2023076299A JP 2023090869 A5 JP2023090869 A5 JP 2023090869A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- iron
- use according
- iii
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102017000085412A IT201700085412A1 (it) | 2017-07-26 | 2017-07-26 | Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare |
| IT102017000085412 | 2017-07-26 | ||
| PCT/IB2018/055586 WO2019021232A1 (en) | 2017-07-26 | 2018-07-26 | Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus |
| JP2020502672A JP2020528888A (ja) | 2017-07-26 | 2018-07-26 | 心血管器官の病態の予防及び処置における使用のための組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020502672A Division JP2020528888A (ja) | 2017-07-26 | 2018-07-26 | 心血管器官の病態の予防及び処置における使用のための組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023090869A JP2023090869A (ja) | 2023-06-29 |
| JP2023090869A5 true JP2023090869A5 (https=) | 2023-08-03 |
Family
ID=60451085
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020502672A Pending JP2020528888A (ja) | 2017-07-26 | 2018-07-26 | 心血管器官の病態の予防及び処置における使用のための組成物 |
| JP2023076299A Pending JP2023090869A (ja) | 2017-07-26 | 2023-05-02 | 心血管器官の病態の予防及び処置における使用のための組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020502672A Pending JP2020528888A (ja) | 2017-07-26 | 2018-07-26 | 心血管器官の病態の予防及び処置における使用のための組成物 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20200206157A1 (https=) |
| EP (1) | EP3657963A1 (https=) |
| JP (2) | JP2020528888A (https=) |
| KR (1) | KR20200032691A (https=) |
| CN (1) | CN111031813A (https=) |
| BR (1) | BR112020000902B1 (https=) |
| CA (1) | CA3070659A1 (https=) |
| CL (1) | CL2020000170A1 (https=) |
| CO (1) | CO2020000526A2 (https=) |
| EA (1) | EA202090069A1 (https=) |
| IL (1) | IL272138B2 (https=) |
| IT (1) | IT201700085412A1 (https=) |
| JO (1) | JOP20200012A1 (https=) |
| MA (1) | MA49794A (https=) |
| MX (1) | MX2020000806A (https=) |
| PE (1) | PE20200794A1 (https=) |
| PH (1) | PH12020550031A1 (https=) |
| WO (1) | WO2019021232A1 (https=) |
| ZA (1) | ZA202000461B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700089258A1 (it) | 2017-08-02 | 2019-02-02 | Pharmanutra S P A | Composizione per uso nella prevenzione e nel trattamento di carenza di ferro |
| WO2019237054A1 (en) | 2018-06-08 | 2019-12-12 | Epizon Pharma, Inc. | Methods and compositions for preventing or treating calciphylaxis |
| IL279245B2 (en) | 2018-06-08 | 2024-03-01 | Epizon Pharma Inc | Compositions comprising menaquinone-7 (mk-7) and/or menquinol for prophylaxis of tissue calcification |
| IT201900007326A1 (it) | 2019-05-27 | 2020-11-27 | Alesco Srl | Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari |
| IT201900007311A1 (it) | 2019-05-27 | 2020-11-27 | Alesco Srl | Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati |
| CN114748486A (zh) * | 2022-03-25 | 2022-07-15 | 南京盛德生物科技研究院有限公司 | 一种含有维生素k2改善心血管钙化的药物组合物及其制备方法与应用 |
| JP2025518284A (ja) | 2022-05-31 | 2025-06-12 | リージョン スイダンマーク | 冠動脈石灰化（ｃａｃ）の治療に使用するためのビタミンｋ２ |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3860849B2 (ja) * | 1994-04-28 | 2006-12-20 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗動脈硬化治療剤 |
| WO1996039053A2 (en) * | 1995-06-06 | 1996-12-12 | Campbell Soup Company | Mineral supplements for dietetic food |
| US6361800B1 (en) * | 2000-04-13 | 2002-03-26 | Cooper Concepts, Inc. | Multi-vitamin and mineral supplement |
| GB0220182D0 (en) * | 2002-08-30 | 2002-10-09 | Cardiovascular Res Inst Maastr | Organic compounds |
| WO2005044189A2 (en) * | 2003-10-28 | 2005-05-19 | Emory University | Dialysates and methods and systems related thereto |
| US20050281888A1 (en) * | 2004-06-16 | 2005-12-22 | Chandra Ranjit K | Nutritional supplement for infants |
| US20060134226A1 (en) * | 2004-11-16 | 2006-06-22 | Todd Leonard | Compositions useful to treat ocular neovascular diseases and macular degeneration |
| MX2008008009A (es) * | 2005-12-23 | 2008-09-12 | Ajay Gupta | Composicion de nutricion parenteral que contiene hierro. |
| JP2009525277A (ja) * | 2006-01-30 | 2009-07-09 | グロボアジア エルエルシー | 軟組織石灰化の回復、予防、遅延または安定化方法 |
| US20100021573A1 (en) * | 2008-07-22 | 2010-01-28 | Michael J Gonzalez | Compositions and methods for the prevention of cardiovascular disease |
| EP2380578A4 (en) * | 2008-12-25 | 2013-09-04 | Ibe Co Ltd | BIOACTIVE AGENT, PHARMACEUTICAL PRODUCT, COSMETIC PRODUCT, AGENT PRESERVING FRESHNESS AND AGENT PROMOTING PLANT AND ANIMAL GROWTH |
| PH12013502396A1 (en) * | 2011-05-20 | 2019-07-17 | Friesland Brands Bv | Composition comprising vitamin k2 |
| ITMI20121350A1 (it) * | 2012-07-31 | 2014-02-01 | Alesco Srl | Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro. |
| EP2886129A1 (en) * | 2013-12-20 | 2015-06-24 | VitaK B.V. | Prevention and counteraction of diet-induced thrombosis risk |
| WO2016131993A2 (en) * | 2015-02-20 | 2016-08-25 | Vitak B.V. | Vitamin k and capillary function |
| US11344575B2 (en) * | 2016-08-15 | 2022-05-31 | Summit Innovation Labs, LLC | Vascular calcification prevention and treatment |
-
2017
- 2017-07-26 IT IT102017000085412A patent/IT201700085412A1/it unknown
-
2018
- 2018-07-26 BR BR112020000902-4A patent/BR112020000902B1/pt not_active IP Right Cessation
- 2018-07-26 IL IL272138A patent/IL272138B2/en unknown
- 2018-07-26 EP EP18762623.9A patent/EP3657963A1/en not_active Withdrawn
- 2018-07-26 KR KR1020207001554A patent/KR20200032691A/ko not_active Ceased
- 2018-07-26 CN CN201880045110.6A patent/CN111031813A/zh active Pending
- 2018-07-26 EA EA202090069A patent/EA202090069A1/ru unknown
- 2018-07-26 PE PE2020000102A patent/PE20200794A1/es unknown
- 2018-07-26 WO PCT/IB2018/055586 patent/WO2019021232A1/en not_active Ceased
- 2018-07-26 US US16/631,426 patent/US20200206157A1/en not_active Abandoned
- 2018-07-26 MX MX2020000806A patent/MX2020000806A/es unknown
- 2018-07-26 CA CA3070659A patent/CA3070659A1/en active Pending
- 2018-07-26 JO JOP/2020/0012A patent/JOP20200012A1/ar unknown
- 2018-07-26 MA MA049794A patent/MA49794A/fr unknown
- 2018-07-26 JP JP2020502672A patent/JP2020528888A/ja active Pending
-
2020
- 2020-01-17 PH PH12020550031A patent/PH12020550031A1/en unknown
- 2020-01-17 CO CONC2020/0000526A patent/CO2020000526A2/es unknown
- 2020-01-20 CL CL2020000170A patent/CL2020000170A1/es unknown
- 2020-01-23 ZA ZA2020/00461A patent/ZA202000461B/en unknown
-
2023
- 2023-05-02 JP JP2023076299A patent/JP2023090869A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023090869A5 (https=) | ||
| JP2020528888A5 (https=) | ||
| Fischl et al. | The intermediate coronary syndrome: clinical, angiographic and therapeutic aspects | |
| JP2022062151A5 (https=) | ||
| FI3750535T3 (fi) | Menetelmiä sydän- ja verisuonitautitapahtumien riskin vähentämiseksi tutkittavalla | |
| Hamdan et al. | Octreotide and low-fat breast milk in postoperative chylothorax | |
| JP2019206562A5 (https=) | ||
| WO2018193648A1 (ja) | アルカリ性化剤による血液浄化 | |
| US20190298753A1 (en) | Methods for treating pulmonary hypertension | |
| PT1635838E (pt) | Inibidores da fosfodiesterase 5 para a profilaxia e/ou terapia da hipertonia portal | |
| Goto et al. | The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease | |
| Oki et al. | Inhaled nitric oxide for ECPELLA management in fulminant myocarditis complicated with severe right ventricular dysfunction: A case report | |
| Nuzzo et al. | Iloprost use in patients with persistent intestinal ischemia unsuitable for revascularization | |
| Tissières et al. | Aerosolized iloprost as a bridge to lung transplantation in a patient with cystic fibrosis and pulmonary hypertension | |
| Rabanal et al. | Perioperative management of pulmonary hypertension during lung transplantation (a lesson for other anaesthesia settings) | |
| EK et al. | Long-term effect of isosorbide dinitrate and nifedipine, singly and in association, in patients with chronic heart failure | |
| De Backer et al. | Oxygenation improvement with nitric oxide in right-to-left shunt without significant effects on pulmonary arterial pressure | |
| Ivanova et al. | POS-008 EXTRARENAL MANIFESTATIONS OF ATYPICAL HEMOLYTIC UREMIC SYNDROME: CARDIAC AND LUNG INVOLVEMENT | |
| Ascenzi et al. | Update on complications of pediatric cardiac surgery | |
| Beirne et al. | Six years' experience with prostaglandin I2 infusion in elective open repair of abdominal aortic aneurysm: a parallel group observational study in a tertiary referral vascular center | |
| JP6364362B2 (ja) | ヒトキマーゼ阻害剤および機能性食品、並びにヒトキマーゼの活性を阻害する方法 | |
| WO2015025816A1 (ja) | キマーゼ阻害剤およびキマーゼ阻害剤を含有する薬剤 | |
| JP2021054725A (ja) | イヌ肺高血圧症治療薬 | |
| Iwano et al. | Clinical utility of echocardiographic hemodynamic monitoring during manual compression of arteriovenous shunt in a patient with high-output heart failure | |
| Ferrannini et al. | Response to comment on Ferrannini et al. Diabetes Care 2016; 39: 1108–1114. Comment on Mudaliar et al. Diabetes Care 2016; 39: 1115–1122 |